AU1048600A - Substance for reduction of cholesterol as well as lipids content - Google Patents

Substance for reduction of cholesterol as well as lipids content

Info

Publication number
AU1048600A
AU1048600A AU10486/00A AU1048600A AU1048600A AU 1048600 A AU1048600 A AU 1048600A AU 10486/00 A AU10486/00 A AU 10486/00A AU 1048600 A AU1048600 A AU 1048600A AU 1048600 A AU1048600 A AU 1048600A
Authority
AU
Australia
Prior art keywords
cholesterol
substance
reduction
well
lipids content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10486/00A
Inventor
Harri Hakli
Harri Pomoell
Elina Saynatjoki
Henryk Struszczyk
Marketta Wulff
Erkki Wuolijoki
Pauli Ylitalo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novasso Oy
Original Assignee
Novasso Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novasso Oy filed Critical Novasso Oy
Publication of AU1048600A publication Critical patent/AU1048600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AU10486/00A 1998-10-23 1999-10-25 Substance for reduction of cholesterol as well as lipids content Abandoned AU1048600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI982291 1998-10-23
FI982291A FI982291A (en) 1998-10-23 1998-10-23 An agent for lowering cholesterol and lipids
PCT/FI1999/000885 WO2000024785A1 (en) 1998-10-23 1999-10-25 Substance for reduction of cholesterol as well as lipids content

Publications (1)

Publication Number Publication Date
AU1048600A true AU1048600A (en) 2000-05-15

Family

ID=8552763

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10486/00A Abandoned AU1048600A (en) 1998-10-23 1999-10-25 Substance for reduction of cholesterol as well as lipids content

Country Status (7)

Country Link
EP (1) EP1144458A1 (en)
JP (1) JP2002528571A (en)
CN (1) CN1331703A (en)
AU (1) AU1048600A (en)
CA (1) CA2347967A1 (en)
FI (1) FI982291A (en)
WO (1) WO2000024785A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002251662B2 (en) * 2001-04-12 2005-04-21 Medicarb Ab An effervescent solid composition of matter
SE522529C2 (en) * 2001-04-12 2004-02-17 Medicarb Ab Effervescent solid composition used for treating dermal wounds comprises chitosan or component releasing carbon dioxide in acidic environment
KR100473445B1 (en) * 2001-05-10 2005-03-08 씨제이 주식회사 cholesterol reducer and health food containing chitosan and ε-polylysine
ES2209632B1 (en) * 2002-08-30 2005-08-01 Romildo Holding, N.V. DIETETIC, SOLUBLE, EFFECTIVE AND FOOD COMPLEMENT.
US20060058261A1 (en) * 2004-09-15 2006-03-16 Andre Aube Chitin derivatives for hyperlipidemia
JP2009519251A (en) * 2005-12-16 2009-05-14 ディーエヌピー・カナダ・インコーポレーテッド Chitin derivatives for hyperlipidemia
AU2007330345A1 (en) * 2006-12-07 2008-06-12 Ben-Bar Technology 2006 Mixture and method for reducing cholesterol using hydrophobic chitosan microparticles
EP2016946B1 (en) * 2007-07-18 2013-02-27 The Jordanian Pharmaceutical Manufacturing Co. Chitosan silicon dioxide coprecipitate composition for use as a therapeutically active agent
CN102469782A (en) 2010-06-18 2012-05-23 哈洛资源公司 Formulations and methods for solid chitosan-containing blends
CN102504291B (en) * 2011-10-28 2014-01-01 北京联合大学生物化学工程学院 pH sensitive type chitosan crosslinking povidone gel and preparation method and application thereof
CN115568321B (en) * 2022-09-16 2024-04-02 江苏省农业科学院 Method for prolonging physiological function period of leaf of Su Cui No. 1 pear

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223023A (en) * 1978-10-12 1980-09-16 Ivan Furda Nonabsorbable lipid binder
FI83426C (en) * 1989-06-30 1991-07-10 Firextra Oy FOERFARANDE FOER KONTINUERLIG FRAMSTAELLNING AV MICROCRYSTALLINE KITOSAN.
JPH07100040B2 (en) * 1992-11-24 1995-11-01 朝日食品工業株式会社 Method for measuring molecular weight distribution of chitosan and / or partially decomposed product thereof
FI107432B (en) * 1997-02-06 2001-08-15 Novasso Oy Use of microcrystalline chitosan

Also Published As

Publication number Publication date
CN1331703A (en) 2002-01-16
JP2002528571A (en) 2002-09-03
EP1144458A1 (en) 2001-10-17
WO2000024785A1 (en) 2000-05-04
CA2347967A1 (en) 2000-05-04
FI982291A (en) 2000-04-24
FI982291A0 (en) 1998-10-23

Similar Documents

Publication Publication Date Title
AU1035199A (en) Method for modification of cellulose
AU2911399A (en) Natural substance based agent
AU1630900A (en) Method for developing answer-options to issue-questions relating to child-development
AUPP337298A0 (en) Process for microgel preparation
AU6462098A (en) Compounds useful as electrodes and method for preparing same
AU2557500A (en) Methods of making compounds
AU2051600A (en) Compositions and methods of modulating cholesterol metabolism
AU3091599A (en) Method of making dimethylnaphtalenes
AU7420298A (en) Method for reducing moisture content
AU7358800A (en) Compositions and methods for modification of skin lipid content
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
AU3422399A (en) Method for the preparation of modified cellulose ethers
AU1048600A (en) Substance for reduction of cholesterol as well as lipids content
AU3938299A (en) Method of altering heartbeat
AU5989098A (en) Substance and method for reduction of lipids and cholesterol
AU5737498A (en) Method for the preparation of alpha-bromo-lactam derivatives
AU1321101A (en) Cholesterol lowering and blood lipids lowering composition
AU6484599A (en) An improved process for the preparation of 7-azaindolyl-3-carboxylic acid
AU3454900A (en) Compositions for reducing blood cholesterol
AU1130901A (en) Method for the preparation of 5-carboxyphthalide
AU9119998A (en) Method of time-to-talk calculation
AU5779998A (en) Process for the preparation of cyanoarylmethylamine
AU1772499A (en) Preparation of isopulegol
AU5534299A (en) Process for preparation of 2-aminothiazolecarboxamide derivatives
AU3817899A (en) Therapy of atherosclerosis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase